Naloxone Market To Surpass US$ 884.8 Mn Threshold By 2026 - Coherent Market Insights

Global NaloxoneMarket, by Strength (0.4 mg/ml, 1mg/ml, 0.4mg/0.4ml, and 4mg/0.1ml andOthers), by Route of Administration (Intranasal, Intramuscular/Subcutaneous,and Intravenous), by Distribution Channel (Hospitals, Clinics, RetailPharmacies, Online Pharmacies, and Others), and by Region (North America, LatinAmerica, Europe, Asia Pacific, the Middle East, and Africa)  was valued at US$ 310.2 Mn in 2017, and isprojected to exhibit a CAGR of 11.4% over the forecast period (2018 – 2026).

Increasing launches of newnaloxone products in market is expected to be one of the major drivers fuelingthe global naloxone market growth in the near future. For instance, in November2015, Adapt Pharma Inc. received the U.S. Food and Drug Administration’s(FDA’s) approval for its Narcan (naloxone HCl) nasal spray 4mg, indicated foremergency treatment of known or suspected opioid overdose. In June 2016, SandozCanada, a division of Novartis AG, launched S.O.S. naloxone hydrochlorideinjection in Canada. In July 2017, Indivior Inc., a subsidiary of IndiviorPlc., received marketing authorization (MA) from the French Regulatory Agency,French National Agency for Medicines and Health Products Safety (ANSM), forNalscue naloxone hydrochloride nasal spray, indicated for emergency treatmentof characterized or suspected opioid overdose, in France.

Browse 47 Market Data Tables and33 Figures spread through 199 Pages and in-depth TOC on Naloxone Market, byStrength (0.4 mg/ml, 1mg/ml, 0.4mg/0.4ml, and 4mg/0.1ml and Others), by Routeof Administration (Intranasal, Intramuscular/Subcutaneous, and Intravenous), byDistribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies,and Others),  and Region (North America,Latin America, Europe, Asia Pacific, the Middle East, and Africa) - GlobalForecast to 2026

* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copyof this report:

Increasing prevalence of opioidoverdosing in key countries such as the U.S. and Canada is expected to increasedemand for naloxone and significantly drive global naloxone market’s growthover the forecast period. For instance, according to data published by Centersfor Disease Control and Prevention (CDC) in 2018, in the U.S. over 630,000people died from a drug overdose from 1999 to 2016, and in 2016 around 66% ofthe 63,600 drug overdose deaths involved an opioid. Furthermore, according tothe same source in 2016 the number of deaths involving opioids overdose (whichinclude prescription opioids, heroin, and fentanyl) was five times higher thanthat in 1999. Favorable reimbursement scenarios for naloxone products is alsoexpected to boost the adoption of products and fuel the global naloxone marketgrowth. For instance, NARCAN nasal spray, a naloxone intranasal spray providedby ADAPT Pharma Inc., has extensive public and private insurance coverage.ADAPT Pharma Inc., entered into an agreement with major Pharmacy BenefitsManagers and insurance companies (including Medicaid) to ensure reasonable andaffordable costs to the patient. According to ADAPT Pharma Inc.’s officialwebsite around 97% of the U.S. insured lives have access to NARCAN Nasal SprayFurthermore, global naloxone market growth is also expected to rise due to thecollective initiatives by government and private organizations for increasingaccessibility of naloxone products for emergency treatment opioid overdose.

In 2017, 47 states andWashington, DC in the U.S. expanded access to naloxone through legislation thatpermits prescriptions to people who are likely to encounter someone who mighttake drug overdose. In 2017, Ontario government provided naloxone kits topolice and fire departments to manage emergency case of opioid overdose.Government offered naloxone kits to all 61 police services and 447 firedepartments in the Ontario.

Browse ResearchReport:

Key Takeaways of the NaloxoneMarket:

The global naloxone market isexpected to exhibit a CAGR of 11.4% over the forecast period (2018 – 2026),owing to frequent product launches, approval, and robust pipeline of novelbiopharmaceutical products

North America held the dominantposition in the global naloxone market and is expected to retain its dominanceover the forecast period (2018 – 2026). This is due to the high rates of opioidoverdose and due to presence of novel naloxone products such as Nacran nasalspray in the region. For instance, in February, Adapt Pharma Inc., launchedNarcan nasal spray 4mg commercially in the U.S. market.

Europe is expected to witnesssignificant growth over the forecast period due to increasing launches of newnaloxone by key players in the region. For instance, in July 2017,, IndiviorInc., a subsidiary of Indivior Plc., received marketing authorization (MA) fromthe French Regulatory Agency ANSM for its new Nalscue naloxone hydrochloridenasal spray, indicated for emergency treatment of characterized or suspectedopioid overdose, in France.

Furthermore, initiatives taken bymanufacturers with regulatory bodies to increase access for naloxone productsin case of emergency is also expected to have a positive impact on globalnaloxone market’s growth. For instance, in 2017, 47 states and Washington, DCin the U.S. have expanded access to naloxone through legislation that permitsprescriptions to people who are likely to encounter someone who might take drugoverdose.

Major players operating in theNaloxone Market include Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma,Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., MundipharmaInternational Limited, Kaleo, Inc., and Kern Pharma, S.L.

Buy-Now this researchreport:

AboutCoherent Market Insights:            

CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.



Name:  Mr. Shah

CoherentMarket Insights 1001 4th Ave,

# 3200Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN:  +050-5539-1737